Diagnosis of CRPC involves monitoring the prostate-specific antigen (PSA) levels, imaging studies, and sometimes a biopsy. A rise in PSA levels, despite low testosterone, often indicates the transition to CRPC. Imaging techniques like MRI and CT scans are used to assess the progression of the disease.
